Pharmaxis Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
5,036.00
57,741.00
14,335.00
13,775.00
49,412.00
Cost of Goods Sold (COGS) incl. D&A
16,011.00
19,254.00
15,485.00
15,448.00
16,417.00
Gross Income
10,975.00
38,487.00
1,150.00
1,673.00
32,995.00
SG&A Expense
30,101.00
23,544.00
21,051.00
20,620.00
16,078.00
EBIT
41,076.00
14,943.00
22,201.00
22,293.00
16,917.00
Unusual Expense
8,783.00
577.00
174.00
-
9,580.00
Non Operating Income/Expense
72.00
3,979.00
3,282.00
707.00
1,113.00
Interest Expense
7,202.00
722.00
676.00
623.00
563.00
Pretax Income
55,254.00
18,344.00
18,556.00
21,506.00
6,259.00
Income Tax
3,436.00
122.00
2,093.00
3,160.00
169.00
Consolidated Net Income
51,818.00
18,466.00
16,463.00
18,346.00
6,428.00
Net Income
51,818.00
18,466.00
16,463.00
18,346.00
6,428.00
Net Income After Extraordinaries
51,818.00
18,466.00
16,463.00
18,346.00
6,428.00
Net Income Available to Common
51,818.00
18,466.00
16,463.00
18,346.00
6,428.00
EPS (Basic)
0.17
0.06
0.05
0.06
0.02
Basic Shares Outstanding
309,024.80
310,908.80
316,931.50
318,515.60
319,671.80
EPS (Diluted)
0.17
0.06
0.05
0.06
0.02
Diluted Shares Outstanding
309,024.80
313,882.30
317,154.50
318,515.60
319,778.30
EBITDA
26,923.00
18,349.00
19,173.00
19,234.00
20,029.00
Non-Operating Interest Income
1,735.00
721.00
1,213.00
703.00
598.00
About Pharmaxis
View Profile
